Strongyloides stercoralis is a worldwide-distributed intestinal nematode affecting mainly humans and dogs. Canine strongyloidosis is generally characterised by diarrhoea, malabsorption and bronchopneumonia, and may be fatal in cases of impaired immunity. In recent years, molecular and epidemiological studies suggested that host-adapted populations of S. stercoralis with different zoonotic potential may exist. Clinical and subclinical cases of S. stercoralis infection have been increasingly diagnosed in imported (France, Belgium, Bulgaria) and locally born dogs in Switzerland, showing that this parasite is currently circulating in Europe. Three of these clinical cases will be described here. All three dogs presented severe disease, characterised by harsh diarrhoea, dehydration, vomiting, respiratory and/or neurologic signs, and needed intensive care and hospitalisation. One of these dogs was related to a Swiss breeding kennel, in which the infection was subsequently diagnosed in several other dogs. Faeces were analysed by three coproscopical methods including (i) the Baermann technique, which consistently identified the typical S. stercoralis first-stage larvae in both clinical and subclinical infections, (ii) the sedimentation-zinc chloride flotation and (iii) sodium acetate-acetic acidformalin concentration (SAFC) methods, which allowed the additional identification of parasitic females and/or eggs in two of the clinical cases. Interestingly, S. stercoralis isolated from all three independent clinical cases exhibited an identical genetic background on the nuclear 18S rDNA (fragment involving hypervariable regions I and IV) and the mitochondrial cytochrome oxidase subunit I (cox1) loci, similar to that of zoonotic isolates from other geographical regions, and not to that of dog-adapted variants. Due to the clinical relevance and zoonotic potential of this parasite, the awareness of both diagnosticians and clinicians is strongly required.
Introduction
Strongyloides stercoralis is a worldwide-distributed intestinal nematode that affects mainly humans and dogs. Higher prevalence is generally observed in tropical and subtropical regions (Thamsborg et al. 2017) . S. stercoralis undergoes a complex life cycle involving both parasitic and free-living generations. Parasitic females are located in the small intestine mucosa and produce eggs containing first-stage rhabditoid larvae (L1) by parthenogenesis, which hatch in the intestine and are shed with the faeces. In the environment, they develop either directly through second-stage rhabditoid larvae (L2) into infective third-stage filariform larvae (L3) (homogonic development) or alternatively, through several stages and moultings into free-living female and male worms that mate and produce a generation of parasitic L3 (heterogonic development) (Thamsborg et al. 2017; Deplazes et al. 2016) . Dogs get mainly infected by percutaneous penetration of L3, or through the oral mucosa. Lactogenic transmission may be possible if the bitch is infected late in gestation or during lactation, but it is considered not common (Shoop et al. 2002) . After infection, L3 migrate to the small intestine via lungs, and reach maturity after two moults, developing into parthenogenetic females. However, the existence of further alternative migration routes was assumed (Schad et al. 1989 ).
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The infection in dogs can be asymptomatic; however, lifethreatening disease characterised by diarrhoea, malabsorption and bronchopneumonia may occur. In case of impaired immunity (e.g. due to illness or administration of immunosuppressive drugs) autoinfection, hyperinfection and extraintestinal dissemination (e.g. trachea, nasal cavities, lungs, oesophagus, stomach, cranial cavity) of the parasite, with severe clinical signs were reported in dogs (Cervone et al. 2016; Genta 1986; Grove et al. 1983; Mansfield et al. 1996; Schad et al. 1984) .
Strongyloides stercoralis was successfully transmitted from humans to dogs experimentally, and it has been largely considered a zoonotic nematode (Deplazes et al. 2016; Thamsborg et al. 2017; Jariwala et al. 2017) . However, since different genotypes have been identified during the last years, this fact has been subject of discussion. It was assumed that host-specialised populations of S. stercoralis may exist, and that zoonotic transmission might occur less frequently than previously thought (Ramachandran et al. 1997; Hasegawa et al. 2010; Thamsborg et al. 2017; Takano et al. 2009 ). Recent comparative studies mainly based on the nuclear 18S rDNA (small subunit, SSU) and the mitochondrial cytochrome oxidase subunit I (cox1) locus revealed the existence of two genetically different populations of S. stercoralis in dogs: one population appeared to be dog-specific, while another population was shared by dogs and humans (Jaleta et al. 2017; Nagayasu et al. 2017) .
Although S. stercoralis infections in dogs may be frequent in some tropical regions, they are considered rare in Europe. Reports on S. stercoralis infections in dogs during the last years (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) (2016) (2017) (2018) in Europe are summarised in Table 1 .
In this study, we present three clinical cases of S. stercoralis infection including one case from a Swiss breeding kennel involving several (imported and locally born) dogs, and two further cases from imported dogs unrelated to the first case. We also provide data on the diagnosis and treatment of this disease. Furthermore, molecular typing of the S. stercoralis isolates involved in the three clinical cases was performed to shed some light on the genetic background and zoonotic potential of canine S. stercoralis parasites circulating in Europe. For better understanding, we first present each case with its outcome and afterwards the molecular characterisation of the isolated parasites from all cases.
Materials and methods
Cases of Strongyloides stercoralis infection in dogs (summarised in Suppl. Table 1) Case 1
A female 11-month-old Yorkshire terrier (Dog No. 1) was presented to the emergency service of the Small Animal Clinic of the Vetsuisse Faculty in Bern with acute diarrhoea, vomiting, anorexia, apathy and chronic respiratory problems. The dog had been imported from France into Switzerland 8 months before and held in a familiar breeding kennel together with 36 other dogs since purchase. During the previous months before diagnosis, the dog received amoxicillin and metacam for 2.5 months (i.e. until 1.5 months before admission) due to a severe respiratory disease, clinically diagnosed as kennel cough by the referring veterinarian, which affected half of the adult dogs and most puppies in the kennel during a total period of 3.5 months (as not all dogs got ill simultaneously). After a short clinical recovery, the dog presented pruritus, and a treatment with dexamethasone (Dexadreson®) was initiated, which was prolonged over 1 month (until admission). Two weeks later, respiratory signs reappeared, and shortly afterwards, diarrhoea was also noted; therefore, amoxicillin and enrofloxacin administration was started few days before admission.
At clinical examination, abdominal breathing, marked loss of weight, and alopecia with desquamation and pustules in neck, legs and perineal regions were noticed. Thoracic radiographs showed a mixed alveolar and interstitial lung pattern, more evident in the periphery of the caudal lobes. Abdominal ultrasonography suggested the presence of hepatopathy, enteropathy and ascites. Blood analyses revealed marked hypoalbuminaemia, hypocalcaemia, hypoglycaemia, hypocobalaminaemia, elevated C-reactive protein (CRP) levels and hypercoagulability. First, a serious protein-losing enteropathy associated with a viral, bacterial or parasitic pneumonia was suspected or, less probable a thromboembolism. Immediately, a therapy based on glucocorticoids in antiinflammatory dose, parenteral glucose infusion (Plasmalyte®), clopidogrel (antiaggregant), cobalamin (250 μg sc, 4 applications at weekly intervals) as well as enrofloxacin (Baytril®) (5 mg/kg/day for 7 days) and fenbendazole (Panacur®) (50 mg/Kg/day 5 days, repeating after 3 days interval) was initiated. Subsequently, further complementary diagnostic methods were performed. Commercial rapid tests for parvovirus, Leptospira and Angiostrongylus vasorum infections (IDEXX Parvo Snap Test; Zoetis Witness Lepto and IDEXX Angio Detect Test) yielded negative results. Next, a coproscopical examination by three different techniques (i.e. SAFC (sodium acetate-acetic acid-formalin concentration); sedimentation-zinc chloride flotation (s.d. 1.35) and Baermann techniques) (Deplazes et al. 2016) was performed at the Institute of Parasitology in Bern. The analysis by the SAFC method was negative. By sedimentation-flotation, a few nematode larvae were observed, but their distinctive morphological characteristics were not clearly recognisable. The Baermann technique, however, revealed a high number of rhabditoid larvae, which were morphologically identified as L1 of S. stercoralis (Fig. 1a-c) . After the first parasitological diagnosis, the glucocorticoid therapy was Imported dogs in quarantine 1989-2016 12 breeds; age: < 1.5 years (n = 17), 2-7 years (n = 3) Sweden (n = 7); Hungary (n = 4); Belgium (n = 2); Finland (n = 1); Poland (n = 1); Latvia (n = 1); Russia (n = 1); UK (n = 1); USA (n = 2). immediately stopped. A coproscopical control 3 days after beginning of fenbendazole therapy still showed viable L1 in the faeces, and diarrhoea and coughing were still present. Consequently, ivermectin (0.2 mg/kg sc) was administered (off-label) once and repeated after 2 weeks. Diarrhoea ceased 24 h after the first ivermectin administration. During the following days, the general condition of the dog improved, and it left the clinic 7 days after admission. At control 10 days later, the respiratory signs disappeared completely, serum albumin levels almost normalised but faeces were still soft. Coproscopical analyses were negative. Subsequently, all dogs from the kennel were coproscopically examined. S. stercoralis L1 were detected by the Baermann method in faeces (several pools) from 33 asymptomatic (or showing only soft faeces) Swiss Yorkshire terriers, in two 9-month-old Yorkshire terriers showing diarrhoea and respiratory problems, which had been imported from Bulgaria 4 months before, and finally in one adult female Swiss Yorkshire with cough. Additionally, Giardia duodenalis cysts were detected in all analysed faecal samples by SAFC, and Isospora canis oocysts were found in faeces from the first dog groups (asymptomatic dogs) by the sedimentation-zinc chloride flotation method. All adult dogs and puppies were treated with fenbendazole (50 mg/kg/day 5 days twice with 3-day interval) and ivermectin in the abovementioned doses. Bitches that were pregnant when the diagnosis was first made were initially treated with selamectin spot-on solution (Stronghold®) and after delivery also with ivermectin. A coproscopical control from all dogs (n = 6 pooled samples according to housing groups) performed 10 days after finishing the second ivermectin treatment was negative for S. stercoralis, but two of the pools were still positive for Giardia.
As further dogs in the kennel showed diarrhoea from time to time, the ivermectin dose was increased to 0.4 mg/kg, and the duration of the treatment was prolonged by the veterinarian of the kennel. Finally, all dogs received a total of 5 ivermectin doses (once 0.2 mg/kg, and four times 0.4 mg/kg). All dogs showed a good tolerance to the medication, except one, which presented transient ataxia and trembling after the first ivermectin dose. After the fourth ivermectin dose, the digestive signs completely disappeared in the kennel.
Case 2
(One month after case 1) A female 3-month-old Chihuahua (Dog No. 2) was transferred to the urgency service of the Small Animal Clinic in Bern by a private Veterinarian after presenting epileptiform episodes that were treated with midazolam. The dog had been imported from France 2 days before. At admission, it was in lateral recumbency, comatose, hypothermic, showing tremors and diarrhoea. Blood analyses revealed hypoglycaemia, metabolic acidosis with low The dog received parenteral glucose infusion, omeprazole, fenbendazole (50 mg/kg for 5 days) and toltrazuril (8 mg/kg/ day for 5 days). Three days after beginning with fenbendazole therapy, live L1 were still present in the faeces and ivermectin was administered (0.2 mg/kg) and recommended to be repeated after 2 weeks. The dog recovered clinically after 5 days of treatment, left the clinic and no further follow-up was possible.
Case 3
(Five months after case 1) A female 5-month-old French bulldog (Dog No. 3) imported from Belgium into Switzerland 2 months earlier was presented to the Small Animal Clinic in Bern with bloody diarrhoea and vomiting. The dog had diarrhoea since it was bought, and since approximately 1 week before admittance, blood was observed in the faeces. A coprological analysis performed at a private veterinary clinic 1 week before (no method was specified) gave negative results. Thoracic radiologic examination showed no abnormalities. After being hospitalised at our veterinary hospital, coprological analyses were performed at the Institute of Parasitology. Numerous S. stercoralis eggs (72.4 [62.1-81.5] × 37.2 [32.3-39.3] μm; n = 7) containing larvae in different evolution stages (Fig. 3a, b) , free rhabditoid L1 (Fig. 3a , b) and parasitic females (Fig. 3c, d) were detected by the sedimentation/flotation and SAFC methods; by Baermann, abundant living L1 were seen. The dog was treated with ivermectin 0.2 mg/kg sc and fenbendazole 50 mg/kg for 5 days. The dog clinically recovered and left the hospital 6 days after admission. The coproscopical control 1 week after initiated the treatment was negative. Cases 1 to 3 are summarised in Suppl. Table 1 .
Molecular characterisation of S. stercoralis isolates
To confirm the microscopical diagnosis and to obtain information on the genetic background and zoonotic potential of S. stercoralis parasites involved in these clinical cases, a molecular characterisation based in the amplification and sequencing of fragments of the mitochondrial cox1 gene and of the nuclear 18S rDNA, including the hypervariable regions (HVR) I and IV was performed ( Table 2 ). The amplified small subunit (SSU) fragment indicating the localization of the HVR I and HVR IV and of the primers used in this study is presented in Fig. 2 in Jaleta et al. (2017) .
Briefly, S. stercoralis L1 were isolated from all three dogs (Dogs No. 1 to 3) by the Baermann method, washed in PBS by centrifugation and conserved at − 20°C until processing. DNA from the larvae was extracted with a commercial kit Table 2 . The obtained sequences were compared with those available in GenBank using the BLAST tool (http://blast.ncbi.nlm.nih.gov/Blast.cgi).
Data availability The DNA sequences obtained from this study are available from GenBank (https://www.ncbi.nlm. nih.gov/genbank) (accession numbers MH932095-MH932103).
Results
PCR products with the expected sizes were obtained in all cases. All amplified products showed 99-100% identity with published S. stercoralis sequences, confirming the morphological diagnosis. The obtained DNA sequences were deposited in GenBank, after trimming of the primers binding region (accession numbers MH932095-MH932103). Interestingly, all three isolates showed the same genetic background with an identical molecular pattern in all three analysed markers. The obtained cox1 sequences (accession no. MH932101-MH932103) showed 100% identity (649/649 bp) with sequences of S. stercoralis (AJ558163.1, LC050212.1) from parasites derived from an isolate originally obtained from a dog in the USA (UPD strain) (Schad et al. 1984; Stoltzfus et al. 2012) . They also showed 100% identity (606/606 pb) with S. stercoralis isolates from dogs from Japan (accession no. LC179456-58; LC179244-53) and from a human patient from Thailand (LC179281), but with only 93% query cover, as only partial cox1 sequences were available in GenBank (Nagayasu et al. 2017) . The polymorphism in the HVR-I observed among isolates of S. stercoralis is a single-base insertion/deletion (indel) that results in a stretch of either four or five thymidine nucleotides within this region (4T or 5T sequence) (Nagayasu et al. 2017) . In this study, the amplified SSU fragment including HVR I (accession no. MH932098-MH932100) displayed an HRV I haplotype with a 4T sequence: 5′-TTTT-ATATT…A-3′. Additionally, a polymorphism A was observed in the polymorphic site 18S rDNA 458T/A, identified at position 458 of the reference AF279916 (Online Resource 1). Following the nomenclature of Jaleta et al. (2017), we named this haplotype as HVR I haplotype VI (Online Resource 1). This haplotype VI was observed previously in S. stercoralis isolates from a dog (accession no. AB453316.1) and a chimpanzee (accession no. AB453314.1) in Japan (Hasegawa et al. 2009 ).
Parasites isolated from Dogs No. 1, 2 and 3 d i s p l a y e d H RV I V h a p l o t y p e A ( 5 ′ -AT T T TGTTTATTTTA-ATAT-3′
). This haplotype has been observed in parasites isolated from dogs, humans and nonhuman primates (Hasegawa et al. 2009 ) and was assumed to characterise the zoonotic population of S. stercoralis (Jaleta et al. 2017) . Moreover, the whole amplified sequence surrounding HVR IV of the parasites in this study (accession no. MH932095-MH932097) showed a 100% identity (680/680 pb) with GenBank sequences of S. stercoralis isolated from the faeces of a h u m a n p a t i e n t i n M y a n m a r ( a c c e s s i o n n o . AB923888.1) (Hino et al. 2014 ). Table 1 ). There are no recent reports from Central Europe. In Austria, S. stercoralis infection was first recorded in a dog in 1974 at the Institute of Parasitology in Vienna, and in two Austrian breeder kennels in the 1980s (Prosl 1985) . In Germany, the parasite was detected in 0.3% of 3329 dogs analysed between 1984 and 1991 at the Institute of Parasitology, University of Veterinary Medicine Hannover (Epe et al. 1993 ). However, it was not observed in further 4012 dogs analysed by the sedimentation/zinc sulphate (s.g 1.3) flotation and Baermann methods between 1998 and 2012 at the same Institute (Epe et al. 2004; Raue et al. 2017) . In the present study, the diagnosis of all cases was performed between December 2017 and May 2018 at the Institute of Parasitology in Bern, and there were no previous records of this parasite in dogs for the last 10 years at the Institute. Although S. stercoralis is generally considered as a tropical parasite, and it seems not well adapted to survive low environmental temperatures, it can nevertheless successfully fulfil its life cycle and disseminate within commercial kennels and dog shelters (Table 1 ) even in cold climates (Eydal and Skírnisson 2016; Dillard et al. 2007; Hamnes et al. 2009 ). This fact, added to the increased national and international transport of dogs (e.g. dog trade, relocation of dogs by animal welfare associations, illegal import, tourism) observed during the last years may favour a wider spreading of this parasite in Europe, thus requiring an appropriate awareness of diagnostic labs, practicing veterinarians and the availability of adequate control measures. In the present study, S. stercoralis infection was detected in imported but also in dogs born in Switzerland. In the Swiss breeding kennel (case 1), the parasite might have been introduced by the dog imported from France (Dog No. 1), but also by one or both dogs imported from Bulgaria (that had diarrhoea since their arrival), or it might have been already present in the kennel before these dogs arrived, remaining undiscovered so far. Since the imported dogs had been in the kennel for several months before the diagnosis was made, the origin of the infection could not be clearly elucidated. On the other hand, Dog No. 2 must be certainly considered as an imported case of strongyloidosis, as the Chihuahua was shedding S. stercoralis larvae when it was brought to the Clinic after being bought in France only 2 days before (prepatent period of S. stercoralis: at least 5 to 21 days). Dog No. 3, originating from a breeding kennel in Belgium, was showing digestive signs since its arrival. The infection might have occurred in the kennel; however, since the animal had been in Switzerland for 2 months before diagnosis (and this exceeds the prepatent period of S. stercoralis) its imported origin can be only suspected but not proven.
In the present study, all three infected and hospitalised dogs showed severe disease needing intensive care. However, milder disease and subclinical infection were also detected in further dogs from the Swiss kennel (case 1). Digestive signs were present in all three hospitalised cases, respiratory signs were additionally observed in Dog No. 1, and neurologic signs only in Dog No. 2, indicating a rather diversity of clinical presentations of this disease (Suppl. Table 1 ). Although S. stercoralis is considered a primary pathogen, concomitant viral, bacterial and parasitic infections can influence the clinical outcome. In the Swiss kennel, underlying respiratory agents as well as G. duodenalis and I. canis infections and prolonged medication, especially with corticosteroids, may have contributed to some extent to the clinical severity observed, and to the dissemination of S. stercoralis within the kennel. Recrudescence of infection, autoinfection and hyperinfection with dissemination of the parasite to extraintestinal organs was observed in infected dogs after administration of high and/or prolonged doses of corticosteroids (Genta 1986; Mansfield et al. 1996; Schad et al. 1984 Schad et al. , 1997 Genta 1989 ). In the case of Dog No. 2, coinfections with the intestinal parasites G. duodenalis and I. canis were diagnosed, which could have also intensified the clinical manifestations.
Regarding coproscopical analyses, eggs in different maturity stages (Dog Nos. 2 and 3) and parasitic females (Dog No. 3) were additionally observed besides the typical L1. It is worth to note that the size of S. stercoralis eggs seems to be quite variable. The eggs observed in this study (62-86 × 32-42 μm) were larger than those reported for S. stercoralis (e.g. 50-58 × 30-34 μm) by Thamsborg et al. (2017) . However, our observations are in agreement with previous reports, in which also a larger size for S. stercoralis eggs after oviposition was observed (Tanaka 1966) . Shimura (1919) described that the eggs of S. stercoralis in dogs had a size of 56-64 × 22-30 μm in the uterus and of 60 × 40 μm after oviposition and Ito (1932) reported sizes of 66-83 × 36-45 μm in the uterus and of 75-88 × 40-60 μm after oviposition (as cited in Tanaka 1966) . Therefore, factors that may influence the size of the eggs such as maturity, possible degradation inside dead females shed with the faeces or mechanical effects during performance of the coproscopical analyses should be considered during the diagnosis. Due to their similar size, S. stercoralis eggs could have been misdiagnosed with hookworm or freeliving nematode eggs (product of intestinal passage through coprophagia); however, this possibility can be disregarded in the present cases as several of the observed eggs in fresh faeces contained already a larvae (hookworm eggs are morulated when shed), and coprophagia was not possible as the dogs were housed in isolated cages in the intensive care station of the clinic.
To the authors' knowledge, no products for the treatment of S. stercoralis infections in dogs are registered so far, and reported treatments were mostly attempted in only one or a few dogs. Some good clinical results and/or clearance of L1 from the faeces seem to have been obtained after off-label administration of ivermectin (0.2-0.8 mg/kg BW one or several doses with different intervals) (Mansfield and Schad 1992; Dillard et al. 2007; Cervone et al. 2016; Thamsborg et al. 2017; Nolan 2001; Umur et al. 2017; Iatta et al. 2018) ; however, this drug appears not to be effective to remove migrating L3 from extraintestinal sites (Mansfield and Schad 1992) . Administration of fenbendazole as monodrug (50 mg/kg BW/day for 5-7 days) (Cervone et al. 2016; Paradies et al. 2017; Eydal and Skírnisson 2016; Itoh et al. 2009 ) or combined with moxydectin-imidacloprid (Advocate®) (Paradies et al. 2017 ) was only partially effective or not effective. There is also one report on the use of febantel (31.5 mg/kg BW) + pyrantel + praziquantel (Drontal Plus®) for 1 day, repeated after 12 days for 3 days with good clinical results (Cvetkovikj et al. 2018) . Unfortunately, in most cases, no long-term follow-up was possible. In this study, the combination of fenbendazole and ivermectin lead to clinical improvement and to the cease of larvae shedding in Dog Nos.1 to 3. In Dog No. 1 also, a long-term follow-up could be carried out. In Dog Nos. 1 and 2, it could be observed that after 3 days of fenbendazole treatment, viable S. stercoralis larvae were still being shed, thus it seems that this drug is not or not highly effective against this parasite, at least as sole treatment. Clinical improvement and cease of larvae shedding were observed only after additional administration of ivermectin.
In the last years, the zoonotic potential of S. stercoralis and the role of dogs as reservoirs for humans has been subject of debate. Due to epidemiological data and to the observed genetic diversity within S. stercoralis, the existence of different host-adapted variants, subspecies or even species has been suggested (Thamsborg et al. 2017; Jaleta et al. 2017; Ramachandran et al. 1997; Hasegawa et al. 2009 Hasegawa et al. , 2010 . Recent molecular studies based on the polymorphism of the mitochondrial cox1 gene and nuclear 18S (hypervariable regions I and IV) rDNA sequences of S. stercoralis revealed that two genetically different populations occurred in dogs living in an endemic region for human and canine strongyloidosis in Cambodia. One population appeared to be restricted to dogs ('dog-adapted') while the other population was present both in dogs and humans ('dog-human shared') of the same region, arguing for its zoonotic character (Jaleta et al. 2017) . These results would support the existence of a zoonotic species (S. stercoralis) and a dog-adapted species (S. canis) (Jaleta et al. 2017) . Also Nagayasu et al. (2017) reported recently the existence of two genetically different lineages of S. stercoralis (type A and type B parasites), mainly characterised by the cox1 sequence (cox1 clades I and II haplotypes define S. stercoralis types A and B respectively). While S. stercoralis type A were isolated from both humans and dogs from different countries (i.e. humans from Japan, Myanmar, Thailand, Laos, Uganda, Central Africa and dogs from Japan and Myanmar), S. stercoralis type B were isolated exclusively from dogs from Myanmar. The authors suggested that type B parasites could represent an ancestral canidadapted S. stercoralis line, from which type A parasites evolved, expanding its host-spectrum to infect humans (Nagayasu et al. 2017) .
However, it is not known if these observations do also apply to parasites from other geographical regions. As the genetic structure of S. stercoralis strains circulating in Europe is largely unknown, we performed a molecular characterisation of the isolates involved in the clinical cases in this study to aid clarifying this issue. Interestingly, in our study, all three European isolates obtained from unrelated dogs had the same genetic background for the considered markers, independent of their origin. This fact suggests that S. stercoralis isolates circulating among kennels/breeders in Europe may be very closely related. A full-genome sequencing approach could figure out if all three isolates are completely identical. This is noteworthy because the cox1 sequence of S. stercoralis was shown to have a great variability, with at least 100 different haplotypes described in isolates from dogs and humans so far (Jaleta et al. 2017; Hasegawa et al. 2010; Laymanivong et al. 2016; Schad et al. 1984; Nagayasu et al. 2017) . The cox1 sequence from all three dogs in our study showed a 100% identity and query cover with GenBank entries (AJ558163.1, LC050212.1) derived from a same S. stercoralis isolate (UPD strain), originally obtained from a dog in the USA (Schad et al. 1984; Stoltzfus et al. 2012) , but with none of the 17 haplotypes identified by Jaleta et al. (2017) . It had also a 100% identity (but only 93% query cover) with S. stercoralis isolates from dogs from Japan (accession No. LC179456-58; LC179244-53) and from a human patient from Thailand (LC179281); however, only partial cox1 sequences (covering 93% of our sequences) were available from these isolates (Nagayasu et al. 2017) . Therefore, we assume that the isolates obtained in our study would be phylogenetically related with parasites within the cox1 Clade I in the study of Nagayasu et al. (2017) , in which both human and dog S. stercoralis isolates clustered, suggesting their zoonotic potential.
The HVR I haplotype detected in the present study (5′ TTTT-ATATT…A 3′) does not belong to any of the haplotypes (I to V) observed in parasites isolated from dogs and humans by Jaleta et al. (2017) ; however, this haplotype was observed previously in isolates from both dogs and nonhuman primates before (accession No. AB453316.1 and AB453314.1). Although the HVR I is highly conserved within many nematode species, it appears to be more variable in S. stercoralis and its usefulness to distinguish dogand human-adapted strains should be further clarified (Nagayasu et al. 2017) . Among the three selected markers, the SSU HVR IV is the most conserved region, and so far, only 2 variants: haplotypes A and B have been described in S. stercoralis (Jaleta et al. 2017) . The two haplotypes differed at three positions (two indels, one base substitution). Haplotype A seems to be the most frequent haplotype and was originally described as the HVR IV sequence of S. stercoralis (Hasegawa et al. 2009 ). Parasites showing this haplotype were isolated from humans and dogs from different geographical regions and also from chimpanzees (Hasegawa et al. 2009 ). In the study from Jaleta et al. (2017) , the HVR IV haplotype A was the only haplotype present in S. stercoralis isolated from humans and it was also found in 22.5% of the worms obtained from dogs, while the haplotype B was exclusively found in dog-derived worms and represented the most frequent haplotype in this species. In the same study, a total of 17 cox1 different haplotypes were observed, 7 of them were associated with HVR IV haplotype A and 10 with HVR IV haplotype B. No cox1 haplotype was shared by both HVR IV haplotypes, accounting for the existence of two different phylogenetic groups. On the other side, same HVR I haplotypes were shared by both groups, suggesting that the HVR I other than the HVR IV does not indicate genetically separated populations. The authors stated that the SSU HVR IV haplotype can be adequate to identify both S. stercoralis populations in dogs and that haplotype A would be a marker for the zoonotic population. Parasites from all dogs in our study presented the HVR IV haplotype A variant accounting for their zoonotic potential, if this assumption proves to be valid. To our knowledge, only the owner of the dogs in case 1 was examined coprologically after our diagnosis in the dogs and tested negative. Nevertheless, transmission from infected dogs to humans was already reported and dogs have been experimentally infected with parasites isolated from humans (Georgi and Sprinkle 1974; Thamsborg et al. 2017; Genta 1989; Grove and Northern 1988) . It should be considered, that not only the presence of infected dogs in the household, but also factors from the host (e.g. level of exposure, immune status, hygiene measures), environment (e.g. humidity, temperature, sanitary conditions, level of contamination) and from the parasite (e.g. parasite burden, genetic background) are needed for the infection to be successfully established.
Conclusions
S. stercoralis infections in dogs may occur and should be considered during the diagnosis of enteritis and respiratory disease. Breeding kennels and animal trade seem to play an important epidemiological role in the dissemination of S. stercoralis. Since routine faecal flotation methods have low sensitivity for detection of L1, and shedding of eggs is considered uncommon, the prevalence, as well as the clinical significance of S. stercoralis in dogs might be underestimated; therefore, the awareness of diagnosticians and practicing veterinarians is required. Moreover, due to its zoonotic potential, a correct diagnosis is pivotal also from the public health point of view. The genetic background of the parasites detected in this study correlates with that of the zoonotic isolates and not with the dog-adapted variants. In the present case, S. stercoralis infection was detected in several dogs in Switzerland, either locally born or imported from other European countries, showing that the parasite is currently circulating in Europe. The combination of fenbendazole and ivermectin (off-label) proved to be effective as treatment. However, no necropsies to ensure a complete absence of adult parasites or migrating larvae after treatment were performed and a long-term follow-up was not possible in all cases.
